Skip to content

The company built to bring clarity to childbirth.

Why Raydiant Oximetry exists.

It started with a question.

Every day, clinicians make some of medicine's most important decisions during labor.

Decisions that can shape the course of two lives.

Yet, for the fetus, one of the body's most fundamental vital signs remained out of reach of clinicians.

For years, pediatric anesthesiologist Dr. Neil Ray cared for mothers and babies in those critical moments.

He saw exceptional teams making difficult decisions without a direct measure of fetal oxygenation.

He began asking a simple question.

If we measure pulse oximetry everywhere else in medicine, why can't we measure it before birth?

That question became Raydiant Oximetry.

Today, clinicians, engineers, scientists, and innovators are working toward the same vision: bringing fetal pulse oximetry into view so every clinical decision can be made with greater clarity and confidence.

Built by experts.

Turning a clinical insight into a new standard of care requires more than a great idea.

It takes clinicians who understand the problem firsthand. Engineers and Scientists who solve complex challenges. Regulatory experts who navigate the path to product approval. And experienced leaders who know how to bring breakthrough technologies to market.

Raydiant is built on that combination of expertise, united by a shared belief that clinicians deserve better information when making life’s most important decisions.

Leadership Team

Mike Nagel

Mike Nagel

CEO

in
Russ DeLonzor

Russ DeLonzor

COO & President

in
Barrett Willich

Barrett Willich

CFO

in
Mark Rosen, MD

Mark Rosen, MD

CMO

in
Paul Stetson

Paul Stetson

CSO

in
Simon Thomas

Simon Thomas

Senior Technology Officer

Eric Johansson

Eric Johansson

VP, R&D

in
Pam Misajon

Pam Misajon

VP, Clinical & Regulatory

in
Denise Malvehy

Denise Malvehy

VP, Global Marketing

in
Bob Skidmore

Bob Skidmore

VP, Operations

in

Board of Directors.

Providing experienced leadership and governance as Raydiant advances fetal oxygen visibility toward clinical practice.

Debra Reisenthel

Debra Reisenthel

Chairwoman of the Board

in
Mike Nagel

Mike Nagel

CEO

in
Annie Theriault

Annie Theriault

Director

in
Elizabeth Bailey

Elizabeth Bailey

Director

in
Charles McDonald

Charles McDonald

Director

in